85 related articles for article (PubMed ID: 26315998)
1. Genetic association between TRAIL-R1 Thr209Arg and cancer susceptibility.
Geng P; Li J; Wang N; Liao Y; Ou J; Sa R; Xie G; Liu C; Li H; Xiang L; Liang H
Sci Rep; 2015 Aug; 5():10382. PubMed ID: 26315998
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
[TBL] [Abstract][Full Text] [Related]
3. TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis.
Chen B; Liu S; Wang XL; Xu W; Li Y; Zhao WH; Wu JQ
Eur J Cancer; 2009 Sep; 45(14):2598-605. PubMed ID: 19643596
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
5. Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.
Chen W; Tang WR; Zhang M; Chang K; Wei YL
Asian Pac J Cancer Prev; 2014; 15(6):2889-92. PubMed ID: 24761920
[TBL] [Abstract][Full Text] [Related]
6. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
[TBL] [Abstract][Full Text] [Related]
7. Role of interferon gamma and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 single nucleotide polymorphism in natural clearance and treatment response of HCV infection.
Azam S; Manzoor S; Imran M; Ashraf J; Ashraf S; Resham S; Ghani E
Viral Immunol; 2015 May; 28(4):222-8. PubMed ID: 25798684
[TBL] [Abstract][Full Text] [Related]
8. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
[TBL] [Abstract][Full Text] [Related]
9. Association of AGTR1 gene A1166C polymorphism with the risk of heart failure: a meta-analysis.
Zhang JA; Li JR; Qiao YJ
Genet Mol Res; 2015 Aug; 14(3):9163-70. PubMed ID: 26345849
[TBL] [Abstract][Full Text] [Related]
10. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
[TBL] [Abstract][Full Text] [Related]
11. The association between common genetic variant of microRNA-146a and cancer susceptibility.
Qiu LX; He J; Wang MY; Zhang RX; Shi TY; Zhu ML; Mao C; Sun S; Lv FF; Zheng CL; Zhu XD
Cytokine; 2011 Dec; 56(3):695-8. PubMed ID: 21978540
[TBL] [Abstract][Full Text] [Related]
12. Association of the G1057D polymorphism in insulin receptor substrate 2 gene with type 2 diabetes mellitus: a meta-analysis.
Jiang F; Li S; Pan L; Jia C
J Diabetes Complications; 2015 Jul; 29(5):731-6. PubMed ID: 25959789
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
14. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
15. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
Qiu LX; Wang Y; Xia ZG; Xi B; Mao C; Wang JL; Wang BY; Lv FF; Wu XH; Hu LQ
Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
[TBL] [Abstract][Full Text] [Related]
16. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
Liu DY; Liang HC; Xiao XM
Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
[TBL] [Abstract][Full Text] [Related]
17. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
[TBL] [Abstract][Full Text] [Related]
18. Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.
Liu LG; Tanaka H; Ito K; Ito T; Sultana TA; Kyo T; Kimura A
Acta Haematol; 2005; 113(2):113-23. PubMed ID: 15802890
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
[TBL] [Abstract][Full Text] [Related]
20. Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects.
Wang F; Fang Q; Yu N; Zhao D; Zhang Y; Wang J; Wang Q; Zhou X; Cao X; Fan X
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):161-74. PubMed ID: 21810896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]